Your session is about to expire
← Back to Search
Other
Amount of Celastrol Administered for Safety Concerns
N/A
Recruiting
Led By Rubin Patel, MD
Research Sponsored by Legend Labz, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one month
Awards & highlights
Study Summary
Five healthy participants with normal sperm counts and motility will ingest increasing doses of celastrol over a period of several days. After each dose ingestion the participants will provide an ejaculate the next day for sperm analysis. The objective is to see if increasing ingestion levels of celastrol will affect the sperm counts and motility of the participants.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ one month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Amount of Sperm in 1 mL of Ejaculate after Celastrol Ingestion
Motility of Sperm in 1 mL of Ejaculate after Celastrol Ingestion
Trial Design
1Treatment groups
Experimental Treatment
Group I: Amount of Celastrol AdministeredExperimental Treatment1 Intervention
Increasing doses of Celastrol to each of five male subjects
Find a Location
Who is running the clinical trial?
Legend Labz, Inc.Lead Sponsor
1 Previous Clinical Trials
35 Total Patients Enrolled
Rubin Patel, MDPrincipal InvestigatorLegend Labz, Inc.
1 Previous Clinical Trials
35 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger